We are committed to serving the best interests of our shareholders. The investor pages that follow are your resource for financial information about Catalyst Biosciences, Inc.
NASDAQ: CBIO$12.140.07 (0.57%)Jul 17, 20184:00 p.m. ET
Delayed at least 15 minutes
Data provided by Nasdaq. Minimum 15 minutes delayed.
Press ReleasesJuly 12, 2018Catalyst Biosciences Announces Multiple Presentations at the Scientific and Standardization Committee Meeting of the International Society on Thrombosis and HaemostasisJuly 10, 2018Catalyst Biosciences Announces Appointment of Grant Blouse, Ph.D., as Vice President of Translational ResearchJune 25, 2018Catalyst Biosciences Joins the Russell 2000® IndexView all press releases »
Reverse Stock Split
|For the 1 for 15 Reverse Stock Split Tax Form, click here|
Targacept Special Dividend
|For the FAQ and additional information, click here.|
Catalyst Biosciences, Inc.
|Josephine Belluardo, Ph.D.|
LifeSci Public Relations